investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Role of PGDH in leukemia pathogenesis
Michael L Cleary
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael L Cleary
Stanford University
Stanford, United States
Related projects
Anthony G Letai
Probing mitochondria and personalizing leukemia therapy with BH3 profiling
Leukaemia
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Andrew A Lane
Targeting Chromatin Modifications in Leukemia with Trisomy 21
Leukaemia
Christophe P Nicot
HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB
Leukaemia
Pathology
Hematology and hematologic malignancies
Alan B. Cantor
Regulation of RUNX1 Multiprotein Complex Formation during Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Effie W Petersdorf
Clinical Significance of MHC Haplotypes in HCT
Leukaemia
Robert Stanley
Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms
Leukaemia
Hematology and hematologic malignancies
Luca Gattinoni
Programming T Cell Fates for Therapeutic Use
Leukaemia
Pathology
Hematology and hematologic malignancies
Kim O'Neill
Cancer Immunology Research at Brigham Young University
Leukaemia